Pharmakon Advisors - aVenture Asset Manager Research
Pharmakon Advisors
Operating Status: Operating
Pharmakon Advisors, LP: Investment and financial planning solutions provider.
Location
New York City, NY, US
Founded
2009
Pharmakon Advisors specializes in providing debt capital to the life sciences industry through BioPharma Credit PLC, a closed-end investment trust. The firm focuses on offering financing solutions to pharmaceutical and biotechnology companies, typically in the form of post-IPO debt and other debt financing structures. Their investments range from $23 million to $575 million, with a particular emphasis on larger deals.
The firm's portfolio includes notable companies such as Akebia Therapeutics, BioCryst Pharmaceuticals, Coherus BioSciences, and Sarepta Therapeutics. Pharmakon Advisors' investment strategy targets established companies in the life sciences sector, providing them with the necessary capital to advance their research, development, and commercialization efforts. Their unique approach offers an alternative funding source for biotech and pharma companies seeking to accelerate growth without diluting equity.
Pharmakon Advisors - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies12
Current Portfolio Count12
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.